Kintor Pharma-B Shares Surge Over 5% in Morning Session on Strategic Skincare Partnership

Stock News03-18

Kintor Pharma-B (09939) saw its shares rise more than 5% during morning trading. At the time of writing, the stock was up 5.54%, trading at HK$4.38, with a turnover of HK$1.9909 million. The increase follows an announcement by Kintor Pharma that its wholly-owned subsidiary has entered into an exclusive strategic cooperation framework agreement with CHICMAX (02145) in the cosmetics sector. The two companies will collaborate deeply on Kintor's cosmetic ingredient KT-939, which is designed for skin brightening and spot reduction. They plan to jointly advance the registration of the ingredient and related products, accelerating its commercialization. The partnership aims to develop what they describe as the "most powerful domestic whitening agent" with significant industry influence.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1134627223?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-18 09:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1134627223","market":"fut","top_or_hot":-1,"title":"Kintor Pharma-B Shares Surge Over 5% in Morning Session on Strategic Skincare Partnership","media":"Stock News","content":"<p>Kintor Pharma-B (09939) saw its shares rise more than 5% during morning trading. At the time of writing, the stock was up 5.54%, trading at HK$4.38, with a turnover of HK$1.9909 million. The increase follows an announcement by Kintor Pharma that its wholly-owned subsidiary has entered into an exclusive strategic cooperation framework agreement with CHICMAX (02145) in the cosmetics sector. The two companies will collaborate deeply on Kintor's cosmetic ingredient KT-939, which is designed for skin brightening and spot reduction. They plan to jointly advance the registration of the ingredient and related products, accelerating its commercialization. The partnership aims to develop what they describe as the \"most powerful domestic whitening agent\" with significant industry influence.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kintor Pharma-B Shares Surge Over 5% in Morning Session on Strategic Skincare Partnership</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKintor Pharma-B Shares Surge Over 5% in Morning Session on Strategic Skincare Partnership\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-03-18 09:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Kintor Pharma-B (09939) saw its shares rise more than 5% during morning trading. At the time of writing, the stock was up 5.54%, trading at HK$4.38, with a turnover of HK$1.9909 million. The increase follows an announcement by Kintor Pharma that its wholly-owned subsidiary has entered into an exclusive strategic cooperation framework agreement with CHICMAX (02145) in the cosmetics sector. The two companies will collaborate deeply on Kintor's cosmetic ingredient KT-939, which is designed for skin brightening and spot reduction. They plan to jointly advance the registration of the ingredient and related products, accelerating its commercialization. The partnership aims to develop what they describe as the \"most powerful domestic whitening agent\" with significant industry influence.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02145","symbol_name":"上美股份","start_time":0,"source_url":"","article_id":"1134627223","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1134627223","pubTimestamp":1773798017,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Kintor Pharma-B (09939) saw its shares rise more than 5% during morning trading. At the time of writing, the stock was up 5.54%, trading at HK$4.38, with a turnover of HK$1.9909 million. The increase...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02145":"上美股份","BK4115":"综合电信业务","LU0455707207.USD":"FIDELITY FUNDS  CHINA INNOVATION \"A\" (USD) INC","LU0541502299.USD":"ALLSPRING  EMERGING MARKETS EQUITY \"I\" (USD) ACC","BK4585":"ETF&股票定投概念","LU2242644610.SGD":"Fidelity China Innovation A-ACC-SGD","LU0541501648.USD":"ALLSPRING  EMERGING MARKETS EQUITY \"A\" (USD) ACC","BK1161":"生物科技","09939":"开拓药业-B","LU0502904849.HKD":"FIDELITY FUNDS  CHINA INNOVATION \"A\" (HKD) ACC","VXUS":"国际股票ETF-Vanguard","SG9999004220.SGD":"Nikko AM Shenton Asia Dividend Equity Fund  SGD","BK1207":"个人用品","BK1515":"抗疫概念","BK4588":"碎股","KT":"韩国电信","BK1574":"生物医药B类股"},"translate_title":"开拓药业-B股早盘因护肤战略合作伙伴关系飙升逾5%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VXUS":1,"KT":1,"09939":1,"02145":1},"content_text":"Kintor Pharma-B (09939) saw its shares rise more than 5% during morning trading. At the time of writing, the stock was up 5.54%, trading at HK$4.38, with a turnover of HK$1.9909 million. The increase follows an announcement by Kintor Pharma that its wholly-owned subsidiary has entered into an exclusive strategic cooperation framework agreement with CHICMAX (02145) in the cosmetics sector. The two companies will collaborate deeply on Kintor's cosmetic ingredient KT-939, which is designed for skin brightening and spot reduction. They plan to jointly advance the registration of the ingredient and related products, accelerating its commercialization. The partnership aims to develop what they describe as the \"most powerful domestic whitening agent\" with significant industry influence.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1134627223","isCrawlerRequest":true}